Electroducer is a start-up developing devices to facilitate, secure and optimise percutaneous valves implantations (aortic, mitral, tricuspid) and complex coronary interventions. These multi-patented devices simplify interventions by shortening the procedures, decreasing costs, radiations and complications and increasing security.
The proof of concept has been published in a multi centric study and a randomized controlled trial demonstrating superiority of the Direct Wire Pacing technique. (Journal of American College of Cardiology Cardiovascular Interventions: DOI 10.1016/j.jcin.2019.09.029) Animal stage has been completed and First In Man study is planned for S1 2020.
The company have been founded Q1 2018 and leaded by worldwide famous Cardiologist and Businessmen with decades of Clinical, Research and Entrepreneur experience. This project brings together a lot of international KOL. Electroducer develops a totally novel technology based on an innovative and proven technique which makes THV and complex PCI procedures Easier, Simpler and Safer.
93 cours Berriat
Date of creation : 2017
Number of employees : 1
+33 (0)6 66 39 10 10
FOLLOW US !
- UroMems Raises €16 Million to Advance Development of Electronic Artificial Urinary Sphincter (eAUS) for Stress Urinary Incontinence
- UroMems Appoints Medical Device Industry Leader Steffen Hovard to Board of Directors
- Commission postpones application of the Medical Devices Regulation to prioritise the fight against coronavirus
By clicking on "Subscribe", You agree to receive the MEDICALPS newsletter and offers every month.
You can easily unsubscribe at any time via the unsubscribe link in each of our emails.
5, avenue du Grand Sablon
38700 La Tronche
Tel. +33 (0)4 76 54 95 63